LA
REGN icon

LBP AM’s Regeneron Pharmaceuticals REGN Stock Holding History

LBP AM’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Buy
3,005
+348
+13% +$237K 0.02% 321
2026
Q1 		$2.05M Sell
2,657
-3,326
-56% -$2.55M 0.03% 274
2025
Q4 		$4.62M Sell
5,983
-12,873
-68% -$8.74M 0.05% 240
2025
Q3 		$10.6M Buy
18,856
+18,295
+3,261% +$10.3M 0.13% 141
2025
Q2 		$295K Hold
561
– – ﹤0.01% 362
2025
Q1 		$356K Hold
561
– – 0.01% 349
2024
Q4 		$400K Sell
561
-10
-2% -$8.39K 0.01% 348
2024
Q3 		$600K Buy
+571
New +$635K 0.01% 326
2024
Q1 		– Sell
-6,191
Closed -$5.44M – 388
2023
Q4 		$5.44M Sell
6,191
-2,815
-31% -$2.32M 0.12% 166
2023
Q3 		$7.41M Buy
9,006
+5,843
+185% +$4.59M 0.16% 148
2023
Q2 		$2.27M Buy
3,163
+1,262
+66% +$973K 0.05% 239
2023
Q1 		$1.56M Sell
1,901
-50
-3% -$37.7K 0.04% 314
2022
Q4 		$1.41M Buy
+1,951
New +$1.44M 0.04% 315

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

LBP AM's REGN Position: Q2 2026 in Review

LBP AM increased its Regeneron Pharmaceuticals (REGN) stake by 13% in Q2 2026, buying an estimated $237K and bringing the position to 3,005 shares worth $1.87M. The position accounts for 0.02% of the portfolio, ranked #321.

LBP AM first reported a position in REGN in Q4 2022 and has held it in 13 quarters since. The position peaked at $10.6M in Q3 2025. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • LBP AM held 3,005 shares of Regeneron Pharmaceuticals worth $1.87M as of Q2 2026.
  • LBP AM bought 348 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $237K.
  • Regeneron Pharmaceuticals made up 0.02% of LBP AM's portfolio in Q2 2026, its #321 holding.
  • LBP AM first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 13 quarters since.
  • LBP AM's Regeneron Pharmaceuticals position peaked at $10.6M in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.